openPR Logo
Press release

Human Vaccines Market: Focused Investment to Develop Vaccines for Epidemics to Augment Demand for Human Vaccines Across Globe

07-05-2017 02:37 PM CET | Health & Medicine

Press release from: Transparency Market Research

Human Vaccines Market: Focused Investment to Develop Vaccines

Vaccination has been promoted as a vital public health intervention across the globe for decades. According to the World Health Organization (WHO), vaccination has reduced the global burden of infectious disease to a great extent. An extremely low risk of serious and fatal side effects associated with vaccines and growing awareness regarding vaccination by various government and non-profit organizations are the key factors driving the human vaccines market.

The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. Extensive promotion and marketing strategies and favorable government support are likely to boost market growth.

Browse Market Research Report @ http://www.transparencymarketresearch.com/human-vaccines-market.html

Conjugates Dominate Human Vaccines Market by Type

On basis of vaccine type, the conjugate vaccines segment accounted for the majority share in the global human vaccines market in 2015. Prevnar, manufactured by Pfizer, Inc., is a conjugate vaccine, which generated a significant revenue of US$6.2 bn globally in 2015 alone. This is a key factor contributing to the dominance of conjugates in the human vaccine market. However, the growing preference for commercial brands available in the market is likely to drive the combination vaccines segment.

The pneumococcal segment accounted for the majority share in the global human vaccines market by product. A large number of products are commercially available in the market and the prevalence of pneumonia is high across several regions. These factors have been known to drive the pneumococcal segment.

By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Factors such as the high prevalence of pneumonia and polio among children across the world are likely to fuel this segment. On the other hand, adult vaccines are expected to expand at the highest CAGR from 2016 to 2024.

By distribution channel, the hospital pharmacies segment accounted for the lion’s share in the global human vaccines market. However, the drugstores segment is projected to expand at a considerable CAGR during the forecast period owing to a dramatically increasing vaccination rate in standalone pharmacies in the U.S.

Strong Government Support Benefits Markets in APAC, LATAM, and Africa

North America was the dominant market for human vaccines in terms of revenue in 2015 owing to the growing demand for vaccination among adults and children. The market is also fueled by the increase in government efforts toward vaccination programs and the fact that most vaccines are available in the U.S.

For more information on this report, fill the form @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16127

Asia Pacific is expected to register the strongest growth in the market for human vaccines. Increasing government efforts toward immunization for various diseases such as polio, flu, rotavirus, and typhoid has been boosting the market. A massive population base is also likely to fuel market growth, especially in China and India. China is likely to dominate the Asia Pacific human vaccines market during the forecast period owing to a large population base and growing government support toward vaccination.

Brazil is likely to be the leading market for human vaccines in Latin America by 2024. A large population base, growing healthcare infrastructure, and a rise in subsidiaries for industry participants are the major factors boosting the human vaccines market in Brazil. GCC plays a significant role in the human vaccines market in the Middle East and Africa, as does South Africa. The market in Africa has been witnessing strong growth due to frequent outbreaks in the region, a rapid rise in vaccination programs, and increasing investments by major players.

Major players operating in the global human vaccines market include AstraZeneca, GlaxoSmithKline plc, Merck & Co. Inc., Pfizer, Inc., Sanofi, and Johnson & Johnson.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Vaccines Market: Focused Investment to Develop Vaccines for Epidemics to Augment Demand for Human Vaccines Across Globe here

News-ID: 610347 • Views: 116

More Releases from Transparency Market Research

Endoscopy Repair MarketSet for Rapid Growth and Trend, by 2025
Global Endoscope Repair Market: Overview An endoscope is an instrument used to view any internal cavity of the human body. Endoscopes are inserted into the body via one of many natural orifices. A high resolution camera at the end of inert tubing allows visualization of the body from inside and makes clinical decision making easier. Endoscopes are made of inert material like polyurethane which resists corrosion from bodily fluids and is
Nasal Oxygen Cannula Marketto Set Phenomenal Growth by 2026
Global Nasal Oxygen Cannula Market: Overview A cannula is any tube inserted into the body. A nasal cannula is an oxygen conduit used to deliver high concentrations of oxygen to patients through the nose. Traditionally made of rubber, current versions are made of plastic and can be connected to any oxygen supply by a pliable universal connector. This allows easy adaptability of this product to any setting, for in patient or
Medically Supervised Weight Loss Service MarketShares, Strategies, and Forecasts …
Global Medically Supervised Weight Loss Service Market: Overview Obesity has reached concerning levels around the world, with an increasing number of people tipping the scales. 69% of Americans are estimated to be overweight or obese at this point in time. Excess weight is increasingly linked with a number of chronic diseases that figure as the top causes of mortality worldwide. Also, popular human aesthetics are pushing people towards a fitter body
Bone Conduction Hearing Devices Market: Business Overview and Global Development …
Global Bone Conduction Hearing Devices Market: Snapshot Growing instances of hearing issues among older population is working as a driving factor for the growth of the global bone conduction hearing devices market. Bone conduction hearing devices are gaining popularity in all worldwide populace owing to their ability to work as a substitute to conventional hearing devices. These devices are used by people who are suffering from hearing issues related to miss

All 5 Releases


More Releases for Vaccines

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in
Meningococcal Vaccines Market Growth by 2028 | GlaxoSmithKline, Polysaccharide M …
Partnerships between the private sector and public institutions have been the chief agenda of global public health initiatives. The last few years have witnessed an increase in several private-public partnerships specifically focussing on vaccine provision in developing countries. Partnerships like the International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control (ICG) help magnify the vaccine outreach to remote areas of the world with the maximum need. The governments of
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year
Pneumococcal Vaccines Market is driven by development of new vaccines
The World Health Organization (WHO) projects that Streptococcus Pneumoniae kills nearly half a million children under the 5 years of age across the globe every year, especially in the developing countries. However, there has been a reduction in the disease in the regions that provide Pneumococcal Conjugate Vaccines (PCV). Introduction of vaccines around the world has significantly reduced disease burden, notably in the developing countries. Key market players are also
Global Veterinary Vaccines Market
The Global Veterinary Vaccines Market was valued at US$ 5,688.7 million in 2015 and is projected to expand at a CAGR of 5.9% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Rise in incidence of food-borne zoonotic diseases along with increase in population of livestock is expected to favor growth of the veterinary vaccines market. According to European food safety authority (EFSA),